Ormutivimab

Tax included
Ormutivimab (rhRIG) is a recombinant human monoclonal antibody, targeting rabies virus. Ormutivimab neutralizes a variety of rabies virus strains. Ormutivimab exhibits potent potency against rabies post-exposure prophylaxis (PEP) model.
MedChemExpress 
HY-P99792

Data sheet

Size
Multiple sizes
Reactivity
Others
Application
COVID-19-anti-virus
CAS
2449086-91-1